In addition to mutations in BMPR2 itself, mutations in a number of components of the BMPR2 signaling pathway are linked to the development of PAH, including ALK1 [35], SMAD8 [36], BMP9 [37], and CAV1 (encoding caveolin-1) [38]. Here, CAV1 is linked to pulmonary arterial hypertension.